The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Resonance Health (RHT) signs an agreement with Thalassaemia International Federation (TIF) to deploy 500 FerriSmart vouchers to low and middle income nations
  • Under the letter of agreement, TIF will engage with National Thalassaemia Associations and physicians to facilitate the use of FerriSmart in clinical management protocols
  • To support TIF, Resonance will provide salary support of EU10,000 (A$15,709) for a dedicated and experienced TIF executive
  • Data collected from the FerriSmart Access Initiative will be used in TIF’s Global Thalassaemia Review, as well as by Resonance Health to improve and refine its product offerings
  • Resonance Health was up 5 per cent, trading at 10.5 cents at 2:40 pm AEDT

Resonance Health (RHT) has signed an agreement with Thalassaemia International Federation.

Through the agreement, Thalassaemia International Federation (TIF) will deploy 500 FerriSmart vouchers to low and middle income countries in Asia, the West Pacific and Europe.

FerriSmart is an AI-driven system for automated real-time measurement of liver-iron concentrate (LIC) in patients, using non-invasive MRI-based technology.

These vouchers will be provided by Resonance Health at no cost.

Under the letter of agreement, TIF will engage with National Thalassaemia Associations and physicians to facilitate the use of FerriSmart to integrate the iron-load monitoring into clinical management protocols.

“FerriSmart is a breakthrough for Thalassaemia patients in low-and-middle income countries where thalassaemia is unfortunately and sadly often sub-optimally managed and the inability to accurately assess LIC contributes to this,” TIF Executive Director Dr. Androulla Eleftheriou said.

Data collected from the FerriSmart Access Initiative will be used in TIF’s Global Thalassaemia Review, as well as by Resonance Health to improve and refine its product offerings.

“Our immediate objective is to ensure that patients and clinicians across the world learn of FerriSmart and have an opportunity to use it and benefit from it,” said Mitchell Wells, Managing Director of Resonance Health.

To support TIF, Resonance will also provide salary support of EU10,000 (A$15,709), paid in instalments over 12 months, for a dedicated and experienced TIF executive.

TIF will also introduce Resonance Health to local leaders, which the company said is a critical part of establishing long-term sustainable commercial product success in new markets.

Resonance Health was up 5 per cent, trading at 10.5 cents at 2:40 pm AEDT.

RHT by the numbers
More From The Market Online
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…